Neuromod Devices, Ltd.
http://www.neuromoddevices.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Neuromod Devices, Ltd.
Neuromodulation Firm Lands €10.5M For Tinnitus Treatment
Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.
Neuromod Names New CSO To Complete TENT-A Tinnitus Trial And Advance Noninvasive Neuromodulation Platform
Neuromod, a Dublin, Ireland-based emerging medical technology firm focusing on noninvasive neuromodulation technologies, has named neurostimulation expert Hubert Lim as its new CSO to conclude the company's TENT-A tinnitus trial in Ireland and Germany.
The A-List: The Trend-Shaping Series A Financings Of 2015
Our 12th annual analysis reveals both an expansion of historical patterns of Series A financings and the emergence of a new group of heavily committed, relatively short-term investors.
Venture Funding Deals, November 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.
Company Information
- Industry
- Medical Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice